Skip to Main Content
Skip Nav Destination

Issues

Case Reports in Oncology 2023 2023, Vol. 16, No. 1

Acknowledgement to Reviewers

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1606–1609. https://doi.org/10.1159/000535257

Case Report

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1598–1605. https://doi.org/10.1159/000533708
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1592–1597. https://doi.org/10.1159/000535468
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1586–1591. https://doi.org/10.1159/000533363
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1579–1585. https://doi.org/10.1159/000535172
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1573–1578. https://doi.org/10.1159/000533785
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1568–1572. https://doi.org/10.1159/000535194
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1558–1567. https://doi.org/10.1159/000534549

Erratum

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1557. https://doi.org/10.1159/000531203

Case Report

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1551–1556. https://doi.org/10.1159/000534202
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1542–1550. https://doi.org/10.1159/000534935
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1536–1541. https://doi.org/10.1159/000535174
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1528–1535. https://doi.org/10.1159/000534802
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1518–1527. https://doi.org/10.1159/000533476
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1508–1517. https://doi.org/10.1159/000535026
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1500–1507. https://doi.org/10.1159/000535097
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1494–1499. https://doi.org/10.1159/000534737
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1490–1493. https://doi.org/10.1159/000534657

Retraction Statement

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1489. https://doi.org/10.1159/000535134

Case Report

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1482–1488. https://doi.org/10.1159/000534847
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1475–1481. https://doi.org/10.1159/000534939
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1466–1474. https://doi.org/10.1159/000534931
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1460–1465. https://doi.org/10.1159/000535072
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1451–1459. https://doi.org/10.1159/000534475
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1443–1450. https://doi.org/10.1159/000534862
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1436–1442. https://doi.org/10.1159/000534702
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1425–1435. https://doi.org/10.1159/000534572
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1415–1424. https://doi.org/10.1159/000533956
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1409–1414. https://doi.org/10.1159/000534711
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1402–1408. https://doi.org/10.1159/000534622
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1395–1401. https://doi.org/10.1159/000534729
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1390–1394. https://doi.org/10.1159/000534135
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1384–1389. https://doi.org/10.1159/000533892
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1378–1383. https://doi.org/10.1159/000533936
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1370–1377. https://doi.org/10.1159/000534685
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1362–1369. https://doi.org/10.1159/000534595
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1353–1361. https://doi.org/10.1159/000534528
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1345–1352. https://doi.org/10.1159/000534609
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1335–1344. https://doi.org/10.1159/000531988
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1324–1334. https://doi.org/10.1159/000534628
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1318–1323. https://doi.org/10.1159/000534527
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1311–1317. https://doi.org/10.1159/000534594
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1306–1310. https://doi.org/10.1159/000534398
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1300–1305. https://doi.org/10.1159/000534557
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1293–1299. https://doi.org/10.1159/000532014
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1287–1292. https://doi.org/10.1159/000533821
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1280–1286. https://doi.org/10.1159/000534177
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1274–1279. https://doi.org/10.1159/000534036
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1267–1273. https://doi.org/10.1159/000534145
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1259–1266. https://doi.org/10.1159/000533441
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1253–1258. https://doi.org/10.1159/000534359
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1245–1252. https://doi.org/10.1159/000534000
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1237–1244. https://doi.org/10.1159/000534241
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1232–1236. https://doi.org/10.1159/000534023
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1223–1231. https://doi.org/10.1159/000534181
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1217–1222. https://doi.org/10.1159/000534150
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1209–1216. https://doi.org/10.1159/000534278
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1203–1208. https://doi.org/10.1159/000534180
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1196–1202. https://doi.org/10.1159/000531637
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1183–1195. https://doi.org/10.1159/000534147
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1172–1182. https://doi.org/10.1159/000533707
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1166–1171. https://doi.org/10.1159/000533198
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1156–1165. https://doi.org/10.1159/000533759
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1148–1155. https://doi.org/10.1159/000534038
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1142–1147. https://doi.org/10.1159/000534060
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1136–1141. https://doi.org/10.1159/000534129
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1129–1135. https://doi.org/10.1159/000534146
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1121–1128. https://doi.org/10.1159/000533999
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1113–1120. https://doi.org/10.1159/000533761
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1107–1112. https://doi.org/10.1159/000533758
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1100–1106. https://doi.org/10.1159/000533826
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1095–1099. https://doi.org/10.1159/000532098
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1087–1094. https://doi.org/10.1159/000533957
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1080–1086. https://doi.org/10.1159/000533783
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1073–1079. https://doi.org/10.1159/000533660
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1066–1072. https://doi.org/10.1159/000534141
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1060–1065. https://doi.org/10.1159/000531925
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1054–1059. https://doi.org/10.1159/000530711
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1048–1053. https://doi.org/10.1159/000533893
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1041–1047. https://doi.org/10.1159/000533829
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1033–1040. https://doi.org/10.1159/000533835
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1028–1032. https://doi.org/10.1159/000533888
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1020–1027. https://doi.org/10.1159/000533760
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1013–1019. https://doi.org/10.1159/000533827
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 1007–1012. https://doi.org/10.1159/000533822
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 999–1006. https://doi.org/10.1159/000533749
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 988–998. https://doi.org/10.1159/000531841
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 980–987. https://doi.org/10.1159/000531836
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 972–979. https://doi.org/10.1159/000530710
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 963–971. https://doi.org/10.1159/000533570
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 954–962. https://doi.org/10.1159/000533519
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 946–953. https://doi.org/10.1159/000532121
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 939–945. https://doi.org/10.1159/000532101
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 935–938. https://doi.org/10.1159/000531843
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 930–934. https://doi.org/10.1159/000533553
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 919–929. https://doi.org/10.1159/000531876
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 912–918. https://doi.org/10.1159/000533269
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 907–911. https://doi.org/10.1159/000533705
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 900–906. https://doi.org/10.1159/000531761
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 893–899. https://doi.org/10.1159/000533571
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 886–892. https://doi.org/10.1159/000533129
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 878–885. https://doi.org/10.1159/000530113
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 871–877. https://doi.org/10.1159/000533572
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 863–870. https://doi.org/10.1159/000533554
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 857–862. https://doi.org/10.1159/000533381
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 846–856. https://doi.org/10.1159/000533373
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 837–845. https://doi.org/10.1159/000533518
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 827–836. https://doi.org/10.1159/000531924
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 818–826. https://doi.org/10.1159/000531992
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 811–817. https://doi.org/10.1159/000529859
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 803–810. https://doi.org/10.1159/000533377
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 797–802. https://doi.org/10.1159/000533440
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 791–796. https://doi.org/10.1159/000531624
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 784–790. https://doi.org/10.1159/000533376
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 779–783. https://doi.org/10.1159/000533382
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 771–778. https://doi.org/10.1159/000533375
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 765–770. https://doi.org/10.1159/000532097
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 759–764. https://doi.org/10.1159/000533220
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 753–758. https://doi.org/10.1159/000533300
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 746–752. https://doi.org/10.1159/000532099
Established Facts

  • Sclerosing epithelioid fibrosarcoma is an ultra-rare and aggressive high-grade fibrosarcoma.

  • Crizotinib is used to treat various ALK-positive metastatic non-small-cell lung carcinomas.

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 739–745. https://doi.org/10.1159/000531986
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 734–738. https://doi.org/10.1159/000532003
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 728–733. https://doi.org/10.1159/000532100
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 718–727. https://doi.org/10.1159/000531991
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 711–717. https://doi.org/10.1159/000531787
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 705–710. https://doi.org/10.1159/000531840
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 698–704. https://doi.org/10.1159/000531839
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 681–697. https://doi.org/10.1159/000533199
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 676–680. https://doi.org/10.1159/000533268
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 670–675. https://doi.org/10.1159/000532010
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 662–669. https://doi.org/10.1159/000532004
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 652–661. https://doi.org/10.1159/000532009
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 645–651. https://doi.org/10.1159/000531842
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 640–644. https://doi.org/10.1159/000531834
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 634–639. https://doi.org/10.1159/000531837
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 628–633. https://doi.org/10.1159/000531133
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 621–627. https://doi.org/10.1159/000531134
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 613–620. https://doi.org/10.1159/000531389
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 604–612. https://doi.org/10.1159/000531471
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 597–603. https://doi.org/10.1159/000530897
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 591–596. https://doi.org/10.1159/000531571
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 585–590. https://doi.org/10.1159/000531835
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 577–584. https://doi.org/10.1159/000530383
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 568–576. https://doi.org/10.1159/000531592
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 558–567. https://doi.org/10.1159/000531433
Highlights

  • •Globally treatment approaches in infants with neuroblastoma and soft tissue metastases are not standardized.

  • •Metastases to the testis and muscles are rare and the prognosis not well documented.

  • •Metastases to the lymph nodes in infants have a favorable prognosis.

  • •The prognosis of soft tissue metastases in infants is influenced by biological characteristics.

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 550–557. https://doi.org/10.1159/000530131
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 543–549. https://doi.org/10.1159/000531572
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 538–542. https://doi.org/10.1159/000530445
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 531–537. https://doi.org/10.1159/000531472
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 525–530. https://doi.org/10.1159/000529069
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 517–524. https://doi.org/10.1159/000531230
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 510–516. https://doi.org/10.1159/000530965
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 503–509. https://doi.org/10.1159/000530547
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 497–502. https://doi.org/10.1159/000531164
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 490–496. https://doi.org/10.1159/000530927
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 484–489. https://doi.org/10.1159/000529895
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 480–483. https://doi.org/10.1159/000530402
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 471–479. https://doi.org/10.1159/000531067
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 461–470. https://doi.org/10.1159/000531490
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 453–460. https://doi.org/10.1159/000530832
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 446–452. https://doi.org/10.1159/000530132
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 437–445. https://doi.org/10.1159/000529831
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 434–436. https://doi.org/10.1159/000530981
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 429–433. https://doi.org/10.1159/000530780
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 412–428. https://doi.org/10.1159/000529502
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 406–411. https://doi.org/10.1159/000530603
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 400–405. https://doi.org/10.1159/000530066
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 393–399. https://doi.org/10.1159/000529866
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 387–392. https://doi.org/10.1159/000530338
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 378–386. https://doi.org/10.1159/000530655
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 372–377. https://doi.org/10.1159/000529830
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 366–371. https://doi.org/10.1159/000530328
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 362–365. https://doi.org/10.1159/000530640
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 353–361. https://doi.org/10.1159/000530265
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 346–352. https://doi.org/10.1159/000530336
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 337–345. https://doi.org/10.1159/000530639
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 331–336. https://doi.org/10.1159/000530264
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 321–330. https://doi.org/10.1159/000530133
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 314–320. https://doi.org/10.1159/000530459
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 308–313. https://doi.org/10.1159/000530337

Retracted Paper

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 300–307. https://doi.org/10.1159/000529731

Case Report

Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 293–299. https://doi.org/10.1159/000530182
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 285–292. https://doi.org/10.1159/000530181
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 279–284. https://doi.org/10.1159/000530154
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 273–278. https://doi.org/10.1159/000529672
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 268–272. https://doi.org/10.1159/000530502
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 262–267. https://doi.org/10.1159/000529730
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 255–261. https://doi.org/10.1159/000530164
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 249–254. https://doi.org/10.1159/000528613
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 240–248. https://doi.org/10.1159/000528697
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 233–239. https://doi.org/10.1159/000529315
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 224–232. https://doi.org/10.1159/000529829
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 216–223. https://doi.org/10.1159/000529813
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 210–215. https://doi.org/10.1159/000530109
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 194–209. https://doi.org/10.1159/000529913
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 188–193. https://doi.org/10.1159/000530009
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 183–187. https://doi.org/10.1159/000529828
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 178–182. https://doi.org/10.1159/000529503
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 173–177. https://doi.org/10.1159/000529894
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 168–172. https://doi.org/10.1159/000528221
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 163–167. https://doi.org/10.1159/000529838
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 157–162. https://doi.org/10.1159/000529736
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 149–156. https://doi.org/10.1159/000526930
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 143–148. https://doi.org/10.1159/000528414
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 135–142. https://doi.org/10.1159/000527229
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 130–134. https://doi.org/10.1159/000527824
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 122–129. https://doi.org/10.1159/000529425
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 115–121. https://doi.org/10.1159/000529470
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 108–114. https://doi.org/10.1159/000529060
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 102–107. https://doi.org/10.1159/000529123
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 94–101. https://doi.org/10.1159/000529182
Subject Area: Oncology
Case Rep Oncol (2023) 16 (1): 88–93. https://doi.org/10.1159/000528821